Tozaro raises €8.1M Series A round

19 February 2024· Bedford, United Kingdom· health, biotech, ai, materials, b2b, deep_hardware

The funds will drive further commercialization of novel synthetic affinity reagents within the cell and gene therapy space and support recruitment efforts to expand in-house expertise.

Investors

LeadMercia Ventures
Also participating
Calculus Capital

About Tozaro

Stage
Series B
Headquarters
Bedford, United Kingdom
Founded
2015
Team Size
21–50
Sectors
healthbiotechaimaterialsb2bdeep_hardware

Source: https://tozaro.com/tozaro-closes-7m-series-a-financing-to-drive-commercialization-in-cell-and-gene-therapy-space/